Starpharma signs new DEP® agreement with MSD
- Written by PR Newswire
MELBOURNE, Australia, Aug. 10, 2022 /PRNewswire/ -- Australian biotechnology company Starpharma today announced it has signed a new DEP® Research Agreement with MSD, the trade name of Merck Sharp & Dohme LLC, Rahway, NJ, USA.
This new DEP® program will generate and evaluate additional DEP® Antibody Drug Conjugates (ADCs).
This...
Read more: Starpharma signs new DEP® agreement with MSD